摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Cyano-4,8-dimethyl-4'-(bromomethyl)-4',5'-dihydropsoralen | 273409-99-7

中文名称
——
中文别名
——
英文名称
3-Cyano-4,8-dimethyl-4'-(bromomethyl)-4',5'-dihydropsoralen
英文别名
3-(Bromomethyl)-5,9-dimethyl-7-oxo-2,3-dihydrofuro[3,2-g]chromene-6-carbonitrile
3-Cyano-4,8-dimethyl-4'-(bromomethyl)-4',5'-dihydropsoralen化学式
CAS
273409-99-7
化学式
C15H12BrNO3
mdl
——
分子量
334.169
InChiKey
FDSVUIRVPGFLFW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    59.3
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF
    申请人:BUCKMAN LABORATORIES INTERNATIONAL, INC.
    公开号:EP1144417A1
    公开(公告)日:2001-10-17
  • US6177424B1
    申请人:——
    公开号:US6177424B1
    公开(公告)日:2001-01-23
  • [EN] 4'-SUBSTITUTED-4',5'-DIHYDROPSORALENS AND THERAPEUTICAL USES THEREOF<br/>[FR] DIHYDROPSORALENES-4', 5' SUBSTITUES EN POSITION 4 ET LEURS UTILISATIONS THERAPEUTIQUES
    申请人:BUCKMAN LABOR INC
    公开号:WO2000032603A1
    公开(公告)日:2000-06-08
    The invention relates to 4'-substituted-4',5'-dihydropsoralen compounds of formula (V). In the formula R is hydrogen, a halogen, CN or an acyl group; T is a halogen, CN, a carboalkoxy group NR?1R2, or (N+R1R2R3)X-, R1 and R2¿ are independently a C¿1?-C6 alkyl, or R?1 and R2¿ together with the nitrogen form a 5-8 member heterocyclic ring, or when T is (N?+R1R2R3)X-, R1 and R2¿ together with the nitrogen form a 5-8 member heterocyclic ring or heterocyclic aromatic ring; R3 is hydroge, a C¿1?-C12 alkyl, or, when R?1 and R2¿ together with the nitrogen form a heterocyclic aromatic ring, R3 is a double bond within the heterocyclic aromatic ring; X is a halide. In another embodiment, the invention relates to processes for preparing 4'-substituted-4',5'-dihydropsoralen compounds described above. The compounds of the invention have beneficial pharmaceutical properties and can be used alone or in pharmaceutical compositions used to treat a proliferative skin disorder and to treat microbial infections in a mammal by administering to the mammal an effective amount of a compound of the invention and then irradiating the mammal with ultraviolet light.
查看更多